Delivery Order SPE2DB20D2104-SPE2DB25FMZSE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trokendi XR 50 mg capsules in a 30-count package, with a contract ceiling value of $1,348.85. The award, issued on May 30, 2025, with an ultimate completion date of June 2, 2025, represents a firm fixed price delivery order with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 30, 2025, for the supply of Trokendi XR 25 mg capsules (30-count) valued at $1,476.35. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for completion by May 1, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,833.96 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 100 mg capsules (30-count) on August 13, 2025. This is a firm fixed price, non-set-aside contract with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of August 14, 2025. The delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,689.54 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 100 mg capsules (30-count). This firm fixed-price, competitively awarded contract with no set-aside designation was executed on July 21, 2025, with an ultimate completion date of July 22, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a $29,860.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Trokendi XR 200 mg capsules (30-count units). The award was made without a set-aside designation through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location. This delivery order represents a child contract action under the...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Trokendi XR 100 mg capsules (30-count). The contract ceiling value is $1,304.52, with an ultimate completion date of May 13, 2025. This is a non-set-aside, competitively awarded delivery order that will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $7,207.55 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 100 mg capsules (30-count) under a firm fixed-price arrangement. The contract, which was competitively awarded without set-aside designation, is scheduled for completion by September 24, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for Trokendi XR 200 mg capsules (30-count) with a ceiling value of $2,107.48. The contract utilizes firm fixed pricing and is classified as a non-set-aside award, indicating it was competitively awarded through open procurement processes. Performance will be executed from the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of May 23, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Trokendi XR 100 mg capsules (30-count packages) with a ceiling value of $3,379.08. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by September 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trokendi XR 50 mg capsules in quantities of 30 units, with a contract value of $1,705.44. This competitively awarded, firm fixed-price delivery order was issued on September 18, 2025, with an ultimate completion date of September 19, 2025. The contract is classified as a child award under a larger contract vehicle and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMZSEDelivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Trokendi XR 50 mg capsules (30-count) with a ceiling value of $2,995.93. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 8, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical supply vehicle valued through December 2026 that enables the company to distribute a broad range of medications and medical supplies to military healthcare systems globally. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare programs. The company's performance under the larger DLA Troop Support Medical IDC demonstrates its capability to fulfill diverse pharmaceutical needs across multiple therapeutic domains, including specialty medications, vaccines, and medical supplies. This delivery order for Trokendi XR—a medication used in neurological treatment—exemplifies the routine execution of orders under the broader contract vehicle that supports worldwide military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 9/5/25 |